The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant. (Q39189758)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 1999

Language	Label	Description	Also known as
English	The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant.	scientific article published on July 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Kristian Schønning

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

B Losman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

M Biller

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Olofsson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

O S Lund

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

B Svennerholm

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J E Hansen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A Bolmstedt

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

454

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

47-52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Neutralizing Antibody Response During Human Immunodeficiency Virus Type 1 Infection: Type and Group Specificity and Viral Escape

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Origin of the HIV-susceptible human CD4+ cell line H9

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Inhibition of HIV type 1 infectivity by coexpression of a wild-type and a defective glycoprotein 120.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Induction of antibodies against epitopes inaccessible on the HIV type 1 envelope oligomer by immunization with recombinant monomeric glycoprotein 120.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Effect of anti-carbohydrate antibodies on HIV infection in a monocytic cell line (U937)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

21 January 2018

The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

based on heuristic

inferred from DOI database lookup

CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2899%2900740-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-5793(99)00740-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10413093%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39189758&oldid=1770859633"